STONY BROOK, N.Y. April 10, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or “the Company”) will debut its security print platform solution featuring the Videojet 1860M continuous inkjet (CIJ) printer at INTERPHEX 2018 in Booth 3957 at the Jacob K. Javits Convention Center in New York City on April 17-19.
“This comprehensive supply chain certification solution allows manufacturers and brands to implement a secure tag, test and track capability into existing production lines quickly,” said Janice Meraglia, Vice President of Government and Military Programs at Applied DNA. “We are looking forward to demonstrating this comprehensive supply chain certification solution at INTERPHEX to pharmaceutical, biotech and medical device companies along with our partner, Videojet.”
Applied DNA’s security platform allows companies to tag, test and track a unique molecular tag applied to products or packaging during the manufacturing process. It provides a supply chain management tool to proactively track items globally, adding another level of protection against counterfeits and diversion, transforming the inkjet code into a comprehensive supply chain certification solution. The platform compliments a range of consumer, corporate and government initiatives:
- Communication of covert code information directly from customer to brand owner
- Serialization being implemented by global pharmaceutical companies
- Authentication for counterfeit avoidance under review by government agencies
SigNature® molecular ink, delivered with a Videojet 1860M printer, is created with the addition of a unique, secure molecular tag and is qualified in both black (V4221M) and invisible (V4259M) which can fluoresce blue under UV.
The molecular tags facilitate traceability of products and packaging, enabling such claims as the forensic certification of origin, authenticity, provenance, quality, ethics, integrity, or sustainability. The print platform features black and clear inks to meet various application needs associated with supply chain management and brand protection. In addition to pharmaceuticals, biopharma and medical devices, the solution crosses other industries such as food and beverage, aero defense/industrial parts and others.
Representatives from Applied DNA and Videojet will be conducting demonstrations at Booth 3957 during the show. For more information, please visit http://adnas.com/inkjet-codes-molecular-traceability/ and http://www.videojet.com/us/homepage/products/inks-and-ribbons/molecular-cij-inks.html.
Continuous Inkjet (CIJ):
- High-speed, non-contact printing
- Variable alphanumeric coding capabilities
- Black CIJ ink optimized for industrial applications
- Invisible CIJ ink that fluoresces blue under ultraviolet light, ideal for covert applications
Videojet 1860M Printer:
- Provides advanced warning of clogging and extra high tension (EHT) trips
- SIMPLICiTY™ interface greatly reduces operator interactions
- Includes industry-first predictive ink build-up sensor and innovative nozzle system
- Optional VideojetConnect™ Remote Service minimizes the need for on-site service calls
For 39 years, INTERPHEX has proven to be the place to find all of the state-of-the-art solutions you need to cost-effectively develop and manufacture quality product. INTERPHEX is the premier pharmaceutical, biotechnology and device development and manufacturing event where you can “Experience Science through Commercialization.” Based in New York, INTERPHEX brings over 11,000 global industry professionals and 650+ leading suppliers together to “Learn It, Experience It, Procure It” through a combination of no-cost technical conference, exhibits, demonstrations and networking events to leverage quality, efficiency and cost-effectiveness in today’s ever-changing global market.
Videojet Technologies is a world-leader in the product identification market, providing in-line printing, coding, and marking products, application specific fluids, and product life cycle services. Our goal is to partner with our customers in the consumer packaged goods, pharmaceutical, and industrial goods industries to improve their productivity, to help protect and grow their brands, and to stay ahead of industry trends and regulations. With our customer application experts and technology leadership in continuous inkjet (CIJ), thermal inkjet (TIJ), laser marking, thermal transfer overprinting (TTO), case coding and labeling, and wide array printing, Videojet has more than 345,000 printers installed worldwide. Our customers rely on Videojet products to print on over ten billion products daily. Customer sales, application, service, and training support is provided by direct operations with over 4,000 team members in 26 countries worldwide. In addition, the Videojet distribution network includes more than 400 distributors and OEMs, serving 135 countries.
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.